Sanofi Puts Up €300M in New Targeted Radiation Cancer Therapy Pact With Orano

Sanofi’s equity investment in the new Orano Med entity comes a month after the pharmaceutical giant struck a €100 million deal to license a clinical-stage radiopharmaceutical developed for neuroendocrine tumors. Orano Med develops targeted cancer therapies based on lead-212, an alpha-emitting isotope. The post Sanofi Puts Up €300M in New Targeted Radiation Cancer Therapy Pact…

Read More

Amid Growing Measles Outbreak, More Americans Are Encountering False Claims About the Measles Vaccine, and Many Aren’t Sure What to Believe

With health officials reporting 800 measles cases in multiple states already this year, most of the public – and most parents – report hearing at least one false claim about measles or the vaccine for it, and many of them aren’t sure what to believe, the latest KFF Tracking Poll on Health Information and Trust…More

Read More

Nordic Capital Acquires Arcadia, Entering the VBC Space

Nordic Capital acquired a majority stake in health data platform Arcadia. Together, the two aim to accelerate the company’s mission of advancing value-based care through AI and data analytics. Arcadia CEO Michael Meucci views the deal as both a validation of the company’s strategy and part of a broader wave of healthcare investments focused on…

Read More